Synapse - Works

Results (5712)

Magnetismm-3: An open-label, multicenter, non-randomized phase 2 study of elranatamab (PF-06863135) in patients with relapsed or refractory multiple myeloma

Meeting Abstract

Lesokhin, A.; Iida, S.; Stevens, D.; Gabayan, A. E.; Ma, W. D.; Sullivan, S.; Raab, M. S.
Blood (2021)

Fulltext@MSK | Save

High-dose methotrexate is not associated with reduction in CNS relapse in patients with aggressive B-cell lymphoma: An international retrospective study of 2300 high-risk patients

Meeting Abstract

Lewis, K. L.; Jakobsen, L. H.; Villa, D.; Bobillo, S.; Smedby, K. E.; Savage, K. J.; Eyre, T. A.; Cwynarski, K.; Caporn, P. L.; Van Zyl, J.; more...
Blood (2021)

Fulltext@MSK | Save

A prospective multicenter study of minimal residual disease assessment using a next-generation immunosequencing assay and CT monitoring for surveillance after frontline treatment in diffuse large B-cell lymphoma

Meeting Abstract

Kumar, A.; Westin, J. R.; Schuster, S. J.; Nowakowski, G. S.; Lossos, I. S.; Copley, D.; Grieve, C.; Jacob, A. P.; Joseph, A.; Laraque, L.; more...
Blood (2021)

Fulltext@MSK | Save

Prognostic factors other than age drive the risk of disease progression in adults with Burkitt lymphoma treated with DA-EPOCH-R

Meeting Abstract

Lakhotia, R.; Dunleavy, K.; Abramson, J. S.; Link, B. K.; Powell, B. L.; Melani, C.; Lucas, A. N.; Steinberg, S. M.; Friedberg, J. W.; Kahl, B. S.; more...
Blood (2021)

Fulltext@MSK | Save

Preliminary safety and efficacy from a multicenter, investigator-initiated phase II study in untreated TP53 mutant mantle cell lymphoma with zanubrutinib, obinutuzumab, and venetoclax (BOVen)

Meeting Abstract

Kumar, A.; Soumerai, J. D.; Abramson, J. S.; Batlevi, C. L.; Chadha, P.; Dogan, A.; Falchi, L.; Flaherty, K.; Friedman, C.; Grieve, C.; more...
Blood (2021)

Fulltext@MSK | Save

Screening for monoclonal gammopathy of undetermined significance: A population-based randomized clinical trial. First results from the Iceland screens, treats, or prevents multiple myeloma (iStopMM) study

Meeting Abstract

Kristinsson, S. Y.; Rögnvaldsson, S.; Thorsteinsdottir, S.; Reed, E. R.; Oskarsson, J. T. T.; Petursdottir, I.; Sigurdardottir, G. A.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B. A.; more...
Blood (2021)

Fulltext@MSK | Save

Pelabresib (CPI-0610) monotherapy in patients with myelofibrosis - Update of clinical and translational data from the ongoing MANIFEST trial

Meeting Abstract

Kremyanskaya, M.; Mascarenhas, J.; Palandri, F.; Vannucchi, A.; Verstovsek, S.; Harrison, C. N.; Bose, P.; Schiller, G. J.; Rampal, R.; Drummond, M. W.; more...
Blood (2021)

Fulltext@MSK | Save

Comparative analysis of mature T-cell and NK/T-cell lymphomas in patients with and without HIV: Results from the NA-ACCORD and complete cohorts

Meeting Abstract

Koh, M. J.; Merrill, M. H.; Koh, M. J.; Stuver, R. N.; Alonso, C. D.; Foss, F. M.; Mayor, A. M.; Gill, M. J.; Epeldegui, M.; Cachay, E.; more...
Blood (2021)

Fulltext@MSK | Save

Chromatin accessibility profiling to increase diagnostic accuracy and refine cell-of-origin classification of mature T-cell lymphomas

Meeting Abstract

Julia, E.; Mareschal, S.; Chebel, A.; Golfier, C.; Müller, T. A.; Lours, C.; Hadj-Hamou, S.; Bissay, N.; Tschanz, M.; Ceribelli, M.; more...
Blood (2021)

Fulltext@MSK | Save

The High Mobility Group A1 chromatin regulator drives immune evasion during MPN progression by repressing genes involved in antigen presentation and immune attack

Meeting Abstract

Kim, J.; Kim, J. H.; Cope, L.; Li, L.; Rampal, R.; Koche, R.; Williams, D. M.; Spivak, J. L.; Moliterno, A. R.; Resar, L.
Blood (2021)

Fulltext@MSK | Save